Sushmita Sen: How are We Doing in Global Clinical Trials and Precision Hematology?
Sushmita Sen, Global Medical Scientific Alliances in Oncology and Hematology at Roche, shared a post on LinkedIn:
“How are we doing in Global Clinical Trials and Precision Hematology?
Two back to back outstanding sessions tried to answer that at the European Hematology Association (EHA) Annual Meeting in Stockholm this afternoon.
Two personal observations from the sessions:
In the first session on multi-regional clinical trials (MRCT), FDA and EMA presented their already known views on the topic.
The existing differences between the two regulators in using evidence from multi-regional trials remain unresolved.
Probably the most insightful talk was on EMA’s thoughts on intrinsic and extrinsic factors within multi-regional data that impacts European populations.
What will it take the two regulators evaluate a study design together?
The second session walked us through the very complex process of In Vitro Diagnostics Regulation (IVDR) and evaluation of companion diagnostics (CDx) in Europe.
The intersection of IVDR with Clinical Trials Regulation (CTR) and Medical Device Regulation (MDR) in regulating diagnostics made my head spin!
I appreciated the panelists walking us through real world scenarios in clinical practice – which illustrated the processes behind the regulations.
Can we simplify the complex regulatory pathways to make Precision Hematology a reality for European patients?
Kudos to Robin Doeswijk, Gauthier Quinonez and the EHA Policy team for organizing these sessions.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders